Transform Research: Embrace the FDA Modernization Act 2.0 with a LIMS for Clinical Trial Management
President Biden approved the FDA Modernization Act 2.0 on December 29, 2022. This legislation essentially challenges the long-standing requirement outlined in the Federal Food, Drug, and Cosmetics Act of 1938, which mandated animal testing for new drug development protocols. Are you ready to embrace the Modernization Act and transform clinical trials?
In our latest blog, we demystify the FDA Modernization Act 2.0 and how it's reshaping clinical research.
Read the blog in which we answer: